Search Within

Maria Themeli

Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. GSK Faculty (11)
  4. Hematologic Malignancies Research (11)
  5. Hematologic Malignancies, Division of (11)
  6. Molecular Pharmacology and Chemistry Program Faculty (11)

More Groups

People
  1. Michel Sadelain (11)
  2. Fabiana Perna (4)
  3. Victor Fedorov (4)
  4. Ly Vu (3)
  5. Christopher Kloss (2)
  6. Eirini Papapetrou (2)

More People

Years
  1. 2016 (1)
  2. 2015 (2)
  3. 2014 (1)
  4. 2013 (3)
  5. 2012 (2)
  6. 2011 (2)
Publications
  1. Blood (3)
  2. Experimental Hematology (2)
  3. Cell Stem Cell (1)
  4. Haematologica (1)
  5. Molecular Therapy - Nucleic Acids (1)
  6. Nature Biotechnology (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. Cell Press (2)
  3. Elsevier Science, Inc. (2)
  4. Nature Publishing Group (2)
  5. American Association for the Advancement of Science (1)
  6. Ferrata Storti Foundation (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Escape mutations, ganciclovir resistance, and teratoma formation in human iPSCs expressing an HSVtk suicide gene
    Journal Article

    Kotini, A. G.; De Stanchina, E.; Themeli, M.; Sadelain, M.; Papapetrou, E. P.
    Molecular Therapy - Nucleic Acids (2016)

    Fulltext@MSK | Save
  • The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells
    Journal Article

    Perna, F.; Vu, L. P.; Themeli, M.; Kriks, S.; Hoya-Arias, R. ; Khanin, R.; Hricik, T.; Mansilla-Soto, J.; Papapetrou, E. P.; Levine, R. L.; more...
    Stem Cell Reports (2015)

    Fulltext@MSK | Save
  • New cell sources for T cell engineering and adoptive immunotherapy
    Journal Article

    Themeli, M.; RivieĢ€re, I.; Sadelain, M.
    Cell Stem Cell (2015)

    Fulltext@MSK | Save
  • Icars: Engineered safety for T cell immunotherapy
    Meeting Abstract

    Fedorov, V.; Themeli, M.; Sadelain, M.
    Haematologica (2014)

    Fulltext@MSK | Save
  • PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses
    Journal Article

    Fedorov, V. D.; Themeli, M.; Sadelain, M.
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
    Journal Article

    Themeli, M.; Kloss, C. C.; Ciriello, G.; Fedorov, V. D.; Perna, F.; Gonen, M.; Sadelain, M.
    Nature Biotechnology (2013)

    Fulltext@MSK | Save
  • Inhibitory chimeric antigen receptors (ICARS) limit undesirable side effects of T-cell therapies
    Meeting Abstract

    Fedorov, V.; Themeli, M.; Sadelain, M.
    Experimental Hematology (2013)

    Fulltext@MSK | Save
  • L3MBTL1: A polycomb protein at the node of crosstalk between the BMP4 and hippo signaling pathways in erythropoiesis
    Meeting Abstract

    Perna, F.; Vu, L. P.; Themeli, M.; Hoya-Arias, R. ; Liu, F.; Wang, L.; Gurvich, N.; Hricik, T.; Papapetrou, E. P.; Moore, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Stepwise optimization of T lymphocyte generation from human ES and IPS cells
    Meeting Abstract

    Themeli, M.; Kloss, C.; Sadelain, M.
    Experimental Hematology (2012)

    Fulltext@MSK | Save
  • Targeting a novel epigenetic silencing mechanism to efficiently upregulate fetal globin gene expression
    Meeting Abstract

    Perna, F.; Vu, L. P.; Themeli, M.; Hoya-Arias, R. ; Zhao, X. Y.; Papapetrou, E. P.; Sadelain, M.; Nimer, S. D.
    Blood (2011)

    Fulltext@MSK | Save